We have also proved that the mutated TLR9-1237CC genotype is associated with a better overall survival (OVS), distant metastasis-free survival (DMFS), and locoregional recurrence-free survival (LRRFS), among all NPC patients. Here, TLR9 is linked to nasopharyngeal carcinoma.